marginally significantp = 0.067
Likewise, the anti-CSF1R antibody treatment in the A20 tumor model resulted in a 39.7% reduction in TAMs ( Figure S5 B), repressed tumor growth (marginally significant, p = 0.067), and abrogated the anticancer efficacy of mp105 ( Figure 3 B).